Navigating the Passage for Better Understanding and Prognosis for Acute Limb Ischemia After Lower-Extremity Revascularization

Mette Søgaard^{1

2}, Nikolaj Eldrup³, Peter Brønnum Nielsen^{1

2}

Affiliations

¹ Department of Cardiology, Aalborg University Hospital, Denmark (M.S., P.B.N.).
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark (M.S., P.B.N.).
³ Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Denmark (N.E.).

Editorial

Mette Søgaard et al. Circulation. 2021.

. 2021 Dec 7;144(23):1842-1844.

doi: 10.1161/CIRCULATIONAHA.121.057577. Epub 2021 Dec 6.

Mette Søgaard^{1

2}, Nikolaj Eldrup³, Peter Brønnum Nielsen^{1

2}

¹ Department of Cardiology, Aalborg University Hospital, Denmark (M.S., P.B.N.).
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark (M.S., P.B.N.).
³ Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Denmark (N.E.).

No abstract available

Keywords: Editorials; acute limb ischemia; anticoagulation; peripheral arterial disease; rivaroxaban.

Comment on

Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Hess CN, Debus ES, Nehler MR, Anand SS, Patel MR, Szarek M, Capell WH, Hsia J, Beckman JA, Brodmann M, Diaz R, Habertheuer P, Leeper NJ, Powell RJ, Sillesen H, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MP. Hess CN, et al. Circulation. 2021 Dec 7;144(23):1831-1841. doi: 10.1161/CIRCULATIONAHA.121.055146. Epub 2021 Oct 12. Circulation. 2021. PMID: 34637332 Clinical Trial.